Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 9 de 9
1.
Cutis ; 105(6): 317-318, 2020 Jun.
Article En | MEDLINE | ID: mdl-32716986

We present a case of brilliant green staining of the fingernails caused by the patient's use of an antiseptic dye to self-treat onychodystrophy. Brilliant green is an antiseptic dye used since at least the early 20th century for the treatment of bacterial infections. It was originally used for wound care and as an anti-inflammatory medication; however, its use for both of these indications is limited. Because of its ease of use, low cost, and accessibility, brilliant green has been promoted for use in resource-poor settings and as an anticancer therapy. Dermatologists should be aware of brilliant green, as well as its indications, common uses, and adverse effects, and should be able to differentiate it from other causes of green nails.


Nails , Quaternary Ammonium Compounds , Humans , Staining and Labeling
2.
Am J Clin Dermatol ; 20(3): 423-442, 2019 Jun.
Article En | MEDLINE | ID: mdl-30806959

Antiretroviral therapy (ART) has revolutionized the treatment and prognosis of people living with HIV (PLHIV). With increased survival and improved overall health, PLHIV are experiencing dermatologic issues both specific to HIV and common to the general population. In this new era of ART, it is crucial for dermatologists to have a strong understanding of the broad range of cutaneous disease and treatment options in this unique population. In this review, we outline the most common skin diseases in PLHIV, including HIV-associated malignancies, inflammatory conditions, and infections, and focus on the role of ART in altering epidemiology, clinical features, diagnosis, and treatment of cutaneous conditions.


Anti-HIV Agents/therapeutic use , Dermatologic Agents/therapeutic use , HIV Infections/complications , Skin Diseases/drug therapy , Clinical Trials as Topic , Diagnosis, Differential , HIV Infections/drug therapy , Humans , Skin Diseases/diagnosis , Skin Diseases/etiology , Treatment Outcome
4.
Int J Dermatol ; 57(7): 776-783, 2018 Jul.
Article En | MEDLINE | ID: mdl-29318582

Nail changes are a common feature of alopecia areata (AA) and are a significant source of cosmetic disfigurement and functional impairment. This review provides an update of the prevalence, clinical and histopathological features, pathogenesis, differential diagnosis, clinical course, prognosis, and management of nail changes in patients with AA. Searches for peer-reviewed journal articles were conducted using the PubMed/MEDLINE database with the search terms "nail changes alopecia areata," "alopecia areata nails," and specific searches on "trachyonychia alopecia areata" and "pitting alopecia areata." Other sources of articles included the reference lists of retrieved articles. Nail changes are a common feature of AA, with an average prevalence of 30%, and can cause significant disfigurement and loss of function. Pitting and trachyonychia were by far the most common manifestations of AA, with an average prevalence of 20 and 8%, respectively. Red spotted lunulae, onycholysis, and punctate leukonychia were other reported findings. Other etiologies, such as onychomycosis or lichen planus, may coexist with or confound the diagnosis. There is limited published data on the clinical manifestations of AA-associated nail changes and therapeutic options. Larger controlled trials are necessary to guide treatment decisions.


Adrenal Cortex Hormones/therapeutic use , Alopecia Areata/complications , Janus Kinase Inhibitors/therapeutic use , Nails, Malformed/drug therapy , Nails, Malformed/etiology , Adrenal Cortex Hormones/administration & dosage , Humans , Nails, Malformed/epidemiology , Nails, Malformed/pathology
9.
J Burn Care Res ; 37(2): e154-60, 2016.
Article En | MEDLINE | ID: mdl-26284634

Little is known about the outcomes of pediatric burn patients in resource-limited and rural locations of the developing world. In March 2013, our pediatric burn unit existing in this setting established an electronic registry of all patients. The authors analyzed the registry to determine overall mortality rates and predictors of mortality, including that of underweight status and body part burned. The secure electronic database of all admissions was reviewed for age, gender, weight, burn percentage (TBSA%), body part burned, cause/place of injury, length of stay, underweight status, surgery performed, reason for discharge, and mortality. Univariable and multivariable logistic regression was used to determine the variables associated with mortality. Kaplan-Meier curves were also analyzed. A total of 211 cases (59.7% male) admitted from March 2013 to June 2014 were reviewed. The median age, %TBSA, and length of stay were 2.0 years (1.3-3.3), 8.0% (5.0-13.4), and 8.5 days (4-14). The overall mortality rate was 15/211 (7.1%). Most injuries were unintentional (93.8%) scalds (85.3%) occurring in the home (98.1%). Two factors were significantly associated with mortality in the final multivariable model: %TBSA (odds ratio = 1.31 for 1% increase in %TBSA; 95% confidence interval = 1.17-1.46) and younger age (odds ratio = 0.20; 0.07-0.63). This study characterizes mortality among patients at a pediatric burn unit serving a rural population in the developing world. The majority of pediatric burns were unintentional scalds occurring in the home. %TBSA and lower age were the strongest predictors of mortality. Burn location and underweight status were not independent predictors of mortality. Overall mortality was 7.1%. These data are applicable to improving outcomes for patients in this burn unit and similar settings of its kind.


Burns/mortality , Child, Preschool , Female , Humans , Infant , Injury Severity Score , Male , Registries , Retrospective Studies , Risk Factors , Tanzania/epidemiology
...